Arcturus Therapeutics (ARCT) vs Relmada Therapeutics (RLMD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Arcturus Therapeutics is the larger company by market cap ($362.8 million vs $346.7 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | ARCT | RLMD |
|---|---|---|
| Share price | $12.77 | $3.25 |
| Market cap | $362.82M | $346.68M |
| 1-day change | -1.81% | -0.91% |
| YTD return | — | -32.71% |
| 1-year return | — | +63.32% |
| 5-year return | — | -86.25% |
| EPS (TTM) | $-3.33 | $-0.91 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $24.17 | $8.00 |
| 52-week low | $5.50 | $1.80 |
| Distance from 52-week high | -47.19% | -59.38% |
| Average volume | 938.70K | 1.34M |
| Shares outstanding | 28.42M | 106.67M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
ARCT vs RLMD FAQ
Which is bigger, Arcturus Therapeutics or Relmada Therapeutics?
Arcturus Therapeutics (ARCT) is larger, with a market capitalization of $362.82M compared with $346.68M for Relmada Therapeutics (RLMD).
Are Arcturus Therapeutics and Relmada Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.